Table 2 Baseline characteristics of the matched individuals in the intervention and control districts

Number of districts, N

47

139

Number of individuals per district, median (Q1–Q3)

186 (106–276)

168 (107–256)

Number of individuals in the study, N

9408

27,318

Federal states

 Baden-Württemberg, n (%)

1513 (16.1%)

4534 (16.6%)

 Bavaria, n (%)

4351 (46.2%)

11,974 (43.8%)

 Hesse, n (%)

593 (6.3%)

2171 (7.9%)

 Lower Saxony, n (%)

1971 (21.0%)

6224 (22.8%)

 Rhineland Palatinate, n (%)

980 (10.4%)

2415 (8.8%)

Characteristics of the individuals

 Women, n (%)

8414 (89.4%)

24,566 (89.9%)

 Age at study entry, mean (SD)

78.8 (2.5)

78.8 (2.5)

 Fracture history before study entry*, n (%)

2834 (30.1%)

8017 (29.3%)

 No care need at study entry^†, n (%)

8371 (89.0%)

24,054 (88.1%)

 Specific anti-osteoporotic drug prescriptions before study entry^‡, n (%)

835 (8.9%)

2248 (8.2%)

Follow-up time:

 Number of individuals with one year of follow-up, N (%)

8070 (85.8%)

23,474 (85.9%)

 Time in days, median (Q1–Q3)

365 (365–365)

365 (365–365)